DHS 35.17(1)(b)4.4. Information on the consumer’s strengths, and current and past psychological, social, and physiological data; information related to school or vocational, medical, and cognitive functioning; past and present trauma; and substance abuse. DHS 35.17(1)(b)5.5. The consumer’s unique perspective and own words about how the consumer views his or her recovery, experience, challenges, strengths, needs, recovery goals, priorities, preferences, values and lifestyle, areas of functional impairment, and family and community support. DHS 35.17 NoteNote: Nothing in this chapter is intended to interfere with the right of providers under s. 51.61 (6), Stats., to use customary and usual treatment techniques and procedures in a reasonable and appropriate manner in the treatment of patients who are receiving services under the mental health system, for the purpose of ameliorating the conditions for which the patients were admitted to the system. DHS 35.17(2)(2) If a consumer is determined to have one or more co-occurring disorders, a licensed treatment professional, mental health practitioner, or a recognized psychotherapy practitioner, shall document the treatments and services concurrently received by the consumer through other providers; whether the clinic can serve the consumer’s needs using qualified staff members or in collaboration with other providers; and any recommendations for additional services, if needed. If a clinic cannot serve a consumer’s needs, independently, or in collaboration with other providers, the clinic shall refer the consumer, with the consumer’s consent, to an appropriate provider. DHS 35.17 HistoryHistory: CR 06-080: cr. Register May 2009 No. 641, eff. 6-1-09. DHS 35.18DHS 35.18 Consent for outpatient mental health services. DHS 35.18(1)(1) If a clinic determines that a consumer is appropriate for receiving outpatient mental health services through the clinic, the clinic shall inform the consumer or the consumer’s legal representative of the results of the assessment. In addition, the clinic shall inform the consumer or the consumer’s legal representative, orally and in writing, of all of the following: DHS 35.18(1)(c)(c) Possible outcomes and side effects of treatment recommended in the treatment plan. DHS 35.18(1)(d)(d) Treatment recommendations and benefits of the treatment recommendations. DHS 35.18(1)(e)(e) Approximate duration and desired outcome of treatment recommended in the treatment plan. DHS 35.18(1)(f)(f) The rights of a consumer receiving outpatient mental health services, including the consumer’s rights and responsibilities in the development and implementation of an individual treatment plan. DHS 35.18(1)(g)(g) The outpatient mental health services that will be offered under the treatment plan. DHS 35.18(1)(h)(h) The fees that the consumer or responsible party will be expected to pay for the proposed services. DHS 35.18 NoteNote: Consumers receiving Medicaid covered services may not be charged any amount in connection with services other than the applicable cost share, if any, specified by the Wisconsin Medicaid Program.
DHS 35.18(1)(j)(j) The means by which a consumer may obtain emergency mental health services during periods outside the normal operating hours of the clinic. DHS 35.18(1)(k)(k) The clinic’s discharge policy, including circumstances under which a patient may be involuntarily discharged for inability to pay or for behavior reasonably the result of mental health symptoms. DHS 35.18(2)(2) If a consumer wishes to receive services through the clinic, the consumer or the consumer’s legal representative, where the consent of the legal representative is required for treatment, shall sign a clinic form to indicate the consumer’s informed consent to receive outpatient mental health services. DHS 35.18(3)(3) If a consumer is prescribed medication as part of the consumer’s treatment plan developed under s. DHS 35.19 (1), the clinic shall obtain a separate consent that indicates that the prescriber has explained to the consumer, or the consumer’s legal representative, if the legal representative’s consent is required, the nature, risks and benefits of the medication and that the consumer, or legal representative, understands the explanation and consents to the use of the medication. DHS 35.18 NoteNote: The consent of the patient or legal representative is not required where treatment is ordered pursuant to a court order for involuntary commitment order.
DHS 35.18 HistoryHistory: CR 06-080: cr. Register May 2009 No. 641, eff. 6-1-09. DHS 35.19(1)(a)(a) A licensed treatment professional, mental health practitioner, or recognized psychotherapy practitioner, shall develop an initial treatment plan upon completion of the comprehensive assessment required under s. DHS 35.17 (1) (b). The treatment plan shall be based upon the diagnosis and symptoms of the consumer and describe all of the following: DHS 35.19(1)(a)1.1. The consumer’s strengths and how they will be used to develop the methods and expected measurable outcomes that will be accomplished. DHS 35.19(1)(a)2.2. The method to reduce or eliminate the symptoms causing the consumer’s problems or inability to function in day to day living, and to increase the consumer’s ability to function as independently as possible.